Unexplained Graft Dysfunction after Heart Transplantation—Role of Novel Molecular Expression Test Score and QTc-Interval: A Case Report
Open Access
- 1 January 2010
- journal article
- Published by Hindawi Limited in Cardiology Research and Practice
- Vol. 2010, 1-5
Abstract
In the current era of immunosuppressive medications there is increased observed incidence of graft dysfunction in the absence of known histological criteria of rejection after heart transplantation. A noninvasive molecular expression diagnostic test was developed and validated to rule out histological acute cellular rejection. In this paper we present for the first time, longitudinal pattern of changes in this novel diagnostic test score along with QTc-interval in a patient who was admitted with unexplained graft dysfunction. Patient presented with graft failure with negative findings on all known criteria of rejection including acute cellular rejection, antibody mediated rejection and cardiac allograft vasculopathy. The molecular expression test score showed gradual increase and QTc-interval showed gradual prolongation with the gradual decline in graft function. This paper exemplifies that in patients presenting with unexplained graft dysfunction, GEP test score and QTc-interval correlate with the changes in the graft function.Keywords
This publication has 16 references indexed in Scilit:
- Relationship between prolonged QTc interval, cardiac allograft dysfunction and elevated molecular gene expression profiling test score after heart transplantationThe Journal of Heart and Lung Transplantation, 2010
- Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart RejectionThe Journal of Heart and Lung Transplantation, 2005
- Nodular Endocardial Infiltrates (Quilty Lesions) Cause Significant Variability in Diagnosis of ISHLT Grade 2 and 3A Rejection in Cardiac Allograft RecipientsThe Journal of Heart and Lung Transplantation, 2005
- Fatal disseminated adenoviral infection in an adult heart transplant patientThe Journal of Heart and Lung Transplantation, 2004
- Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients.1995
- Diagnosis of posttransplantation lymphoproliferative disorder by endomyocardial biopsy in a cardiac allograft recipient.1994
- Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies.1992
- A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation.1990
- VASCULAR (HUMORAL) REJECTION IN HEART-TRANSPLANTATION - PATHOLOGIC OBSERVATIONS AND CLINICAL IMPLICATIONS1989
- CYTOMEGALOVIRUS MYOCARDITIS AS A CAUSE OF CARDIAC DYSFUNCTION IN A HEART TRANSPLANT RECIPIENTTransplantation, 1989